Notice to Participate in PA-16-164 "Administrative Supplements for Research on Sleep Disturbances and Impact on Chronic Pain (Admin Supp)"
Notice NOT-AR-16-016 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - May 18, 2016 Category: Research Source Type: funding
DoD Gulf War Illness Epidemiology Research Award
Funding Opportunity Number: W81XWH-16-GWIRP-GWIERA Opportunity Category: DiscretionaryFunding Instrument Type: Cooperative AgreementGrantCategory of Funding Activity: Science and Technology and other Research and DevelopmentCFDA Number: 12.420Eligible Applicants Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"Agency Name: DOD-AMRAAClosing Date: Oct 20, 2016Award Ceiling: $0Expected Number of Awards: 1Creation Date: May 13, 2016Funding Opportunity Description: The Gulf War Illness Epide...
Source: Grants.gov - May 13, 2016 Category: Research Tags: Science and Technology and other Research and Development Source Type: funding
DoD Gulf War Illness Treatment Evaluation Award
Funding Opportunity Number: W81XWH-16-GWIRP-TEA Opportunity Category: DiscretionaryFunding Instrument Type: Cooperative AgreementGrantCategory of Funding Activity: Science and Technology and other Research and DevelopmentCFDA Number: 12.420Eligible Applicants Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"Agency Name: DOD-AMRAAClosing Date: Oct 20, 2016Award Ceiling: $0Expected Number of Awards: 4Creation Date: May 13, 2016Funding Opportunity Description: The Treatment Evaluation Awar...
Source: Grants.gov - May 13, 2016 Category: Research Tags: Science and Technology and other Research and Development Source Type: funding
Prescription Drug Abuse (R01)
Funding Opportunity Number: PA-16-233 Opportunity Category: DiscretionaryFunding Instrument Type: GrantCategory of Funding Activity: EducationHealthCFDA Number: 93.279Eligible Applicants State governmentsCounty governmentsCity or township governmentsSpecial district governmentsIndependent school districtsPublic and State controlled institutions of higher educationNative American tribal governments (Federally recognized)Public housing authorities/Indian housing authoritiesNative American tribal organizations (other than Federally recognized tribal governments)Nonprofits having a 501(c)(3) status with ...
Source: Grants.gov - May 10, 2016 Category: Research Tags: Education Health Source Type: funding
Prescription Drug Abuse (R21)
Funding Opportunity PA-16-232 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages applicants to develop innovative research applications on prescription drug abuse, including research to examine the factors contributing to prescription drug abuse; to characterize the adverse medical, mental health and social consequences associated with prescription drug abuse; and to develop effective prevention and service delivery approaches and behavioral and pharmacological treatments. Applications to address these issues are encouraged across a broad range of methodological appro...
Source: NIH Funding Opportunities (Notices, PA, RFA) - May 10, 2016 Category: Research Source Type: funding
Prescription Drug Abuse (R01)
Funding Opportunity PA-16-233 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages applicants to develop innovative research applications on prescription drug abuse, including research to examine the factors contributing to prescription drug abuse; to characterize the adverse medical, mental health and social consequences associated with prescription drug abuse; and to develop effective prevention and service delivery approaches and behavioral and pharmacological treatments. Applications to address these issues are encouraged across a broad range of methodological approa...
Source: NIH Funding Opportunities (Notices, PA, RFA) - May 10, 2016 Category: Research Source Type: funding
Notice of National Institute of Neurological Disorders and Stroke (NINDS) Participation in PA-16-164 "Administrative Supplements for Research on Sleep Disturbances and Impact on Chronic Pain (Admin Supp)"
Notice NOT-NS-16-020 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 26, 2016 Category: Research Source Type: funding
Notice of National Institute of Neurological Disorders and Stroke (NINDS) Participation in PA-16-164 "Administrative Supplements for Research on Sleep Disturbances and Impact on Chronic Pain (Admin Supp)"
(Source: NINDS Funding Announcements: National Institute of Neurological Disorders and Stroke)
Source: NINDS Funding Announcements: National Institute of Neurological Disorders and Stroke - April 26, 2016 Category: Neurology Source Type: funding
Notice of Change and Informational Webinar for RFA-HL-16-009 "NHLBI SBIR Phase IIB Bridge Awards to Accelerate the Commercialization of Technologies for Heart, Lung, Blood, and Sleep Disorders and Diseases (R44)"
Notice NOT-HL-16-317 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 19, 2016 Category: Research Source Type: funding
Small Market Awards: SBIR Phase IIB Competing Renewals for Heart, Lung, Blood, and Sleep Technologies with Small Commercial Markets (R44)
Funding Opportunity Number: RFA-HL-17-012 Opportunity Category: DiscretionaryFunding Instrument Type: GrantCategory of Funding Activity: HealthCFDA Number: 93.23393.35093.83793.83893.83993.840Eligible Applicants Small businessesAgency Name: HHS-NIH11Closing Date: Jun 20, 2018Award Ceiling: $3,000,000Expected Number of Awards: Creation Date: Apr 18, 2016Funding Opportunity Description: The purpose of the NHLBI SBIR Phase IIB Small Market Award is to provide support to Phase II SBIR or STTR awardees developing NHLBI mission-related technologies that address a rare disease or young pe...
Source: Grants.gov - April 19, 2016 Category: Research Tags: Health Source Type: funding
NHLBI TOPMed Program: Integrative Omics Approaches for Analysis of TOPMed Data (U01)
Funding Opportunity Number: RFA-HL-17-011 Opportunity Category: DiscretionaryFunding Instrument Type: Cooperative AgreementCategory of Funding Activity: HealthCFDA Number: 93.23393.83793.83893.83993.840Eligible Applicants State governmentsCounty governmentsCity or township governmentsSpecial district governmentsIndependent school districtsPublic and State controlled institutions of higher educationNative American tribal governments (Federally recognized)Public housing authorities/Indian housing authoritiesNative American tribal organizations (other than Federally recognized tribal governments)Nonprof...
Source: Grants.gov - April 19, 2016 Category: Research Tags: Health Source Type: funding
NHLBI TOPMed Program: Integrative Omics Approaches for Analysis of TOPMed Data (U01)
Funding Opportunity RFA-HL-17-011 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites applications to join the NHLBI Trans Omics for Precision Medicine (TOPMed) program, which is using high throughput omics technologies to characterize molecular abnormalities or signatures associated with heart, lung, blood, and sleep disorders, to conduct analyses of data generated by this program, and build and share tools for advanced genomic data analysis through the TOPMed information commons. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 18, 2016 Category: Research Source Type: funding
Small Market Awards: SBIR Phase IIB Competing Renewals for Heart, Lung, Blood, and Sleep Technologies with Small Commercial Markets (R44)
Funding Opportunity RFA-HL-17-012 from the NIH Guide for Grants and Contracts. The purpose of the NHLBI SBIR Phase IIB Small Market Award is to provide support to Phase II SBIR or STTR awardees developing NHLBI mission-related technologies that address a rare disease or young pediatric populations. The goal of this FOA is for these technologies to be further validated so that development can continue with private funding after NHLBI support ends. Applicants must submit a Commercialization Plan that includes details on any independent third-party funding that has already been secured or is anticipated during the proje...
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 18, 2016 Category: Research Source Type: funding
Notice of Extension of the Response Date for NOT-HL-16-312 "Request for Information (RFI): Input on Revisions for the NIH Sleep Disorders Research Plan"
Notice NOT-HL-16-316 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 15, 2016 Category: Research Source Type: funding
Request for Information (RFI): Input on Revisions for the NIH Sleep Disorders Research Plan
Notice NOT-HL-16-312 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 8, 2016 Category: Research Source Type: funding
